Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of ALDH3A1 expression with tumor differentiation, pathological stage, and nodal status in oral squamous cell carcinoma. | J Taibah Univ Med Sci | 2025 | 40657474 | PubTator, text mining | PubMed |
| GPerturb: Gaussian process modelling of single-cell perturbation data. | Nat Commun | 2025 | 40593897 | PubTator, text mining | PubMed |
| Dual roles and therapeutic potential of ALDH3 family members in cancer. | Chem Biol Interact | 2025 | 40571176 | PubTator, text mining | PubMed |
| Fluorescent substrates enable specific detection and structure-function insights into human aldehyde dehydrogenase isoforms. | Chem Biol Interact | 2025 | 40541648 | PubTator, text mining | PubMed |
| Lian Qiao Wen Dan Decoction attenuates gastric carcinogenesis by alleviating oxidative phosphorylation dysfunction. | Phytomedicine | 2025 | 40499219 | PubTator, text mining | PubMed |
| Preventing MSC aging and enhancing immunomodulation: Novel strategies for cell-based therapies. | Regen Ther | 2025 | 40453699 | PubTator, text mining | PubMed |
| Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen. | Pharmaceuticals (Basel) | 2025 | 40283974 | PubTator, text mining | PubMed |
| Identification and exploration of key genes associated with radioresistance in lung adenocarcinoma. | Cancer Cell Int | 2025 | 40253319 | PubTator, text mining | PubMed |
| NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer. | Mol Cancer | 2025 | 40089784 | PubTator, text mining | PubMed |
| Transcriptional Profiling of Patients With Fuchs Endothelial Corneal Dystrophy With and Without Trinucleotide Repeat Expansion in TCF4. | Cornea | 2025 | 39998965 | PubTator, text mining | PubMed |
| Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. | Exp Cell Res | 2025 | 39971175 | PubTator, text mining | PubMed |
| Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells. | Oncotarget | 2025 | 39969205 | PubTator, text mining | PubMed |
| Expression of PAX6 and Keratocyte-Characteristic Markers in Human Limbal Stromal Cells of Congenital Aniridia and Healthy Subjects, In Vitro. | Curr Eye Res | 2025 | 39791356 | PubTator, text mining | PubMed |
| Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design. | Bioorg Chem | 2025 | 39689509 | PubTator, text mining | PubMed |
| Macromolecular crowding agent dependent extracellular matrix deposition and growth factor retention in human corneal fibroblast cultures. | Exp Eye Res | 2025 | 39571777 | PubTator, text mining | PubMed |
| Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer. | Carcinogenesis | 2025 | 39526455 | PubTator, text mining | PubMed |
| ALDH Enzymes and Hematological Diseases: A Scoping Review of Literature. | Discov Med | 2024 | 39726306 | PubTator, text mining | PubMed |
| Corneal strain influences keratocyte proliferation and migration through upregulation of ALDH3A1 expression. | FASEB J | 2024 | 39652089 | PubTator, text mining | PubMed |
| Robust self-supervised learning strategy to tackle the inherent sparsity in single-cell RNA-seq data. | Brief Bioinform | 2024 | 39550222 | PubTator, text mining | PubMed |
| NFE2L2 and ferroptosis resistance in cancer therapy. | Cancer Drug Resist | 2024 | 39534872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=4